![]() |
|
|
Osaka Prefectural Institute of Public Health (H.Y., K.I., T.S.) and
Department of Biochemistry and Center in Molecular Toxicology,
Vanderbilt University School of Medicine (C.G.T., F.P.G.)
Effects of freezing, thawing, and storage at room temperature of
human liver samples on the contents and catalytic activities of
individual forms of cytochrome P450 (P450 or CYP) were examined. The
stability of liver genomic DNA was also investigated. There were no
significant decreases in microsomal levels or catalytic activities of
P450 enzymes by storage at
80°C for 5 years. We then examined the
effects of freezing/thawing of liver samples. Levels of P450 forms were
determined immunochemically and by the activities of typical drug
oxidation reactions in liver microsomes of human samples, which were
divided into two groups. One group of samples was thawed and kept at
25°C for 6 hr and then frozen again and kept for 1 week at
80°C.
In the other group, liver microsomes were prepared at the same time (as
those from the other group), but not thawed and refrozen. Thawing the
liver samples and storage for 6 hr at 25°C decreased contents of
total P450 by about 90% and activities of both NADH-ferricyanide and
NADPH-cytochrome c reductases by about 80%. However, the
decrease in b5 levels was only about
30%. Spectral studies of P450 suggested that thawing the liver samples
and holding them at 25°C produced inactive form P420. P450 proteins
were detected by immunoblot analysis with or without thawing, but
catalytic activities for individual P450s were decreased drastically by
thawing and holding samples for 6 hr at 25°C. Only 10% of
tolbutamide methyl hydroxylation activity was present, and there was no
detectable ethoxyresorufin O-deethylation activity in such
microsomes after thawing and holding samples for 6 hr at 25°C.
Genomic DNA from human livers was also found to be degraded after the
samples were thawing. These results suggested that thawing and holding
the liver samples at 25°C decreased the levels and activities of
P450s in microsomes and that there are differences in stabilities in
individual forms of P450 proteins. P450 proteins determined
immunochemically do not always reflect P450-catalytic functions in
human liver microsomes because of difficulties in obtaining fresh liver
samples.
This article has been cited by other articles:
![]() |
Z. E. Barter, J. E. Chowdry, J. R. Harlow, J. E. Snawder, J. C. Lipscomb, and A. Rostami-Hodjegan Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling Drug Metab. Dispos., December 1, 2008; 36(12): 2405 - 2409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. van Liempd, J. Kool, W. M. A. Niessen, D. E. van Elswijk, H. Irth, and N. P. E. Vermeulen On-line Formation, Separation, and Estrogen Receptor Affinity Screening of Cytochrome P450-Derived Metabolites of Selective Estrogen Receptor Modulators Drug Metab. Dispos., September 1, 2006; 34(9): 1640 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Wong, N. Wu, D. Roccatano, M. Zacharias, and U. Schwaneberg Sensitive Assay for Laboratory Evolution of Hydroxylases toward Aromatic and Heterocyclic Compounds J Biomol Screen, April 1, 2005; 10(3): 246 - 252. [Abstract] [PDF] |
||||
![]() |
S. C. Chen, L. Zhou, X. Ding, and S. S. Mirvish Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3 Drug Metab. Dispos., September 1, 2001; 29(9): 1221 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schwaneberg, C. Otey, P. C. Cirino, E. Farinas, and F. H. Arnold Cost-Effective Whole-Cell Assay for Laboratory Evolution of Hydroxylases in Escherichia coli J Biomol Screen, April 1, 2001; 6(2): 111 - 117. [Abstract] [PDF] |
||||
![]() |
T. Shimada, F. Tsumura, and H. Yamazaki Prediction of Human Liver Microsomal Oxidations of 7-Ethoxycoumarin and Chlorzoxazone with Kinetic Parameters of Recombinant Cytochrome P-450 Enzymes Drug Metab. Dispos., November 1, 1999; 27(11): 1274 - 1280. [Abstract] [Full Text] |
||||
![]() |
T. Shimada, J. Watanabe, K. Kawajiri, T. R. Sutter, F. P. Guengerich, E. M.J. Gillam, and K. Inoue Catalytic properties of polymorphic human cytochrome P450 1B1 variants Carcinogenesis, August 1, 1999; 20(8): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||